MedTrace Logo

Interest of the Automated Management of Deep Neuromuscular Blockade Monitoring (CURATP)

NCT05784610 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-03-27

No results posted yet for this study

Summary

Neuromuscular blockade (NMB) recommendations updated in 2018 by the Société Française d'Anesthésie et Réanimation (SFAR) recommend the use of NMB agents to facilitate surgical procedure during abdominal surgery by laparotomy or laparoscopy.

This study aims to evaluate deep NMB monitoring with automated management of NMB depth measurement (ATP mode) versus non-automated monitoring (PTC/TOF), in order to improve the maintenance of deep NMB during abdominal surgery.

Conditions

  • Neuromuscular Blockade

Interventions

DEVICE

Monitorage by TOF/PTC

Installation of TOFscan® and monitoring by MAR appreciation on one of the patient's wrists and installation of TOFscan® and monitoring by ATP mode (MAR blind) on the other wrist Installation of TOFscan® and monitoring by ATP mode

DEVICE

Monitorage by ATP

Installation of TOFscan® and monitoring by ATP mode on one of the patient's wrists

Sponsors & Collaborators

  • Poitiers University Hospital

    lead OTHER

Principal Investigators

  • MATTHIEU M BOISSON, Professor · University Center Hospital of Poitiers

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05784610 on ClinicalTrials.gov